Jefferies Starts Adlai Nortye Ltd. (ANL) at Buy Sep 10, 2026 06:10AM
Adlai Nortye doses first patient in AN4035 global Phase I trial Sep 8, 2026 07:01AM
Lucid Capital Markets Starts Adlai Nortye Ltd. (ANL) at Buy Sep 8, 2026 06:37AM
Adlai Nortye clears regulatory hurdle for AN4035 cancer drug trial Aug 3, 2026 07:02AM
Cantor Fitzgerald Starts Adlai Nortye Ltd. (ANL) at Overweight Jun 22, 2026 06:13AM


May 28, 2026 06:32AM Oppenheimer Starts Adlai Nortye Ltd. (ANL) at Outperform
May 14, 2026 08:08AM Jones Trading Starts Adlai Nortye Ltd. (ANL) at Buy
Mar 20, 2026 06:09AM Leerink Partners Starts Adlai Nortye Ltd. (ANL) at Outperform
Feb 13, 2026 09:38AM H.C. Wainwright Upgrades Adlai Nortye Ltd. (ANL) to Buy
Jan 29, 2026 06:05AM Lucid Capital Markets Starts Adlai Nortye Ltd. (ANL) at Buy
Jun 2, 2025 11:19AM H.C. Wainwright Downgrades Adlai Nortye Ltd. (ANL) to Neutral
Oct 18, 2024 06:45AM H.C. Wainwright Reiterates Buy Rating on Adlai Nortye Ltd. (ANL)
Sep 4, 2024 06:12AM H.C. Wainwright Starts Adlai Nortye Ltd. (ANL) at Buy
Aug 8, 2024 08:02AM Adlai Nortye (ANL) Appoints Roger Sawhney to Its Board